Advertisement
UK markets closed

  • FTSE 100

    8,139.83
    +60.97 (+0.75%)
     

  • FTSE 250

    19,824.16
    +222.18 (+1.13%)
     

  • AIM

    755.28
    +2.16 (+0.29%)
     

  • GBP/EUR

    1.1679
    +0.0022 (+0.19%)
     

  • GBP/USD

    1.2494
    -0.0017 (-0.13%)
     

  • Bitcoin GBP

    51,074.72
    -566.61 (-1.10%)
     

  • CMC Crypto 200

    1,327.24
    -69.30 (-4.96%)
     

  • S&P 500

    5,099.96
    +51.54 (+1.02%)
     

  • DOW

    38,239.66
    +153.86 (+0.40%)
     

  • CRUDE OIL

    83.66
    +0.09 (+0.11%)
     

  • GOLD FUTURES

    2,349.60
    +7.10 (+0.30%)
     

  • NIKKEI 225

    37,934.76
    +306.28 (+0.81%)
     

  • HANG SENG

    17,651.15
    +366.61 (+2.12%)
     

  • DAX

    18,161.01
    +243.73 (+1.36%)
     

  • CAC 40

    8,088.24
    +71.59 (+0.89%)
     
PROPERTY:

9 luxury homes to consider if money is no object

Ever thought about what a multimillion pound budget would buy you?

Portfolio Update

Oxford Technology 3 VCT plc

The Board notes the announcement made yesterday by Arecor Therapeutics plc ("Arecor"), one of the Company's investee companies, to seek to have its shares admitted to trading on AIM, RNS No: 6941Y.

Assuming the placing and admission takes place at a share price in the range indicated, the Company's value of its investment in Arecor is anticipated to increase. The Board intends to make a further announcement that will quantify that impact, after the admission has taken place.

For further information contact:

Oxford Technology Management

Lucius Cary

01865 784466